Collectively, our results imply that the decrease of NAV3 expression levels in GBM likely stems from a large tumor core containing necrotic regions, exhibiting low NAV3, rather than being indicative of a tumor suppressor role of NAV3 in glioma cells. Here, NAV3 is linked to glioma.